drugset / Trial / NCT04783753
Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects
Non-randomizedSingle-groupOpen-labelBasic science
Summary
Non-randomized, 3-part, open-label, drug-drug interaction (DDI) study to evaluate the effect of itraconazole, carbamazepine, or quinidine on the PK and safety of EDP-514 in healthy adult subjects.
Timeline
- Start
- 2020-11-05
- Primary completion
- 2021-06-28
- Completion
- 2021-07-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carbamazepin | Unknown | — | — |
| Subject | EDP-514 | Unknown | — | — |
| Subject | Itraconazole | Small molecule | — | — |
| Subject | Quinidine | Small molecule | — | — |